Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis.
[Symptoms of obsessive-compulsive disorder in neurological diseases].
Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry.
Monooxygenase substrates mimic flavin to catalyze cofactorless oxygenations.
Assessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported Data.
Therapy with Eculizumab for Patients with CD59 p.Cys89Tyr Mutation.
Transneuronal Degeneration of Thalamic Nuclei following Middle Cerebral Artery Occlusion in Rats.
Which gait parameter can be used to evaluate gait improvement in multiple sclerosis?
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation.
Cytokine regulation by modulation of the NMDA receptor on astrocytes.
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.
Neuromyelitis optica spectrum initially diagnosed as antiphospholipid antibody myelitis.
TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.
Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
Acute inflammatory demyelinating polyradiculoneuropathy in a newborn infant.
Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
Electroconvulsive Therapy in Multiple Sclerosis.
Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future.
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis.
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.
Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective.
Internet-Supported Physical Exercise Training for Persons with Multiple Sclerosis-A Randomised, Controlled Study.

Pages